How the 3D architecture of the brain shapes cancer cell fate decisions

Information

  • Research Project
  • 10245406
  • ApplicationId
    10245406
  • Core Project Number
    DP2NS127705
  • Full Project Number
    1DP2NS127705-01
  • Serial Number
    127705
  • FOA Number
    RFA-RM-20-012
  • Sub Project Id
  • Project Start Date
    9/30/2021 - 3 years ago
  • Project End Date
    8/31/2024 - 2 months ago
  • Program Officer Name
    FOUNTAIN, JANE W
  • Budget Start Date
    9/30/2021 - 3 years ago
  • Budget End Date
    8/31/2024 - 2 months ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/23/2021 - 3 years ago

How the 3D architecture of the brain shapes cancer cell fate decisions

Project Summary/Abstract In preliminary studies, my colleagues and I used a single cell RNA sequencing to profile gene expression within individual cells of pediatric brain tumors. My single cell profiles provided the first direct evidence of a concept long suspected but never directly tested ? namely that pediatric brain cancers arise from relatively uncommitted neural progenitors that become developmentally stalled in a replication-competent state. That being said, my preliminary observations have a central limitation ? namely that scRNAseq destroys information about spatial relationships: who is next to whom within the tumor and within the brain? Why should we care about nearest neighbor relationships between tumor cells and the cellular components of normal brain? The answer is embedded within an emerging body of data highlighting functional interactions between tumor and tumor microenvironment. Within brain tumors, cell division, fate choice decisions, development and survival are regulated by short range interactions between presenter and receiver cell types. All of these informative cell:cell interactions are erased by conventional genomic profiling methods including scRNAseq. I propose here that combinatorial transcriptional codes identified by scRNAseq can localize cancer stem cells and cancer cell subtypes in 3D-space within the brain where conventional immunochemical markers fail. To test this proposal, I will (i) generate combinatorial transcriptional codes unique to the various cancer cells and tumor-associated normal cells from my existing single cell dataset; (ii) design specific primers for these combinatorial identifiers and; (iii) visualize cell:cell contacts by performing in situ sequencing on patient-derived tumor samples and on normal brain tissue samples. I will focus on pediatric gliomas, the most common tumor type of childhood. My study plan has two question-oriented, hypothesis-driven aims and a third goal-oriented aim (with a useful deliverable). Aim one asks why some cells within high grade gliomas exit the replication competent state to differentiate while others remain replication competent. Is the developmental cue intrinsic (i.e. a developmental ?clock?) or extrinsic (e.g. a short range ligand:receptor interaction)? Aim two asks why some gliomas invade and others do not. I will use methodology summarized above to test the hypothesis that malignant or benign phenotypes are an outcome of differential ?addictions? to local mitogenic signals from normal neural cell types. Aim three is to expand my data sets on glioma into a tumor-wide single cell atlas of normal cell contacts with most major forms of pediatric brain cancer.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    DP2
  • Administering IC
    NS
  • Application Type
    1
  • Direct Cost Amount
    900000
  • Indirect Cost Amount
    702000
  • Total Cost
    1602000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    OD:1602000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    DANA-FARBER CANCER INST
  • Organization Department
  • Organization DUNS
    076580745
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    022155450
  • Organization District
    UNITED STATES